Basic Catapres Information

• INN (International Nonproprietary Name): Clonidine.
• Brand Names Available In Canada (English): Catapres (tablets 0.1 mg, 0.2 mg, 0.3 mg) and Catapres-TTS (transdermal patches) are the primary brands referenced in product dossiers.
• ATC Code: C02AC01.
• Forms & Dosages: Tablets 0.1 mg, 0.2 mg, 0.3 mg; extended‑release tablets 0.1 mg and 0.17 mg (ER brands in some markets); transdermal patches 0.1–0.3 mg/24 hr equivalents; injection 100 mcg/mL (Duraclon).
• Manufacturers In Canada (English): Not specified.
• Registration Status In Canada (English): Not specified.
• OTC / Rx Classification: Prescription‑only (Rx) in nearly all jurisdictions.

Latest Research Highlights

Are you wondering what recent studies say about catapres and clonidine?

International systematic reviews from 2022–2025 continue to characterise clonidine as an effective centrally acting antihypertensive for select adult patients and as an adjunctive option for paediatric ADHD when using extended‑release formulations.

Canadian pharmacoepidemiology using real‑world claims data highlights persistence issues in older adults due to sedation and orthostatic symptoms.

Randomized controlled trials internationally reinforce benefit for ADHD with bedtime extended‑release dosing and clearer daytime tolerability when titrated slowly.

Safety signals through 2024 emphasise a prolonged elimination half‑life in severe renal impairment and a clear risk of rebound hypertension with abrupt cessation.

• Study Limitations:
  • Heterogeneity in formulations (immediate vs ER vs patch) complicates pooling of effects.
  • Many RCTs are international and may not reflect Canadian formulary availability or dosing practices.
  • Observational claims data lack granular clinical details such as baseline frailty or home BP monitoring.

Data Highlight: Elimination half‑life may be prolonged up to 41 hours in severe renal impairment.

Clinics in Canada emphasise careful titration and shared decision making, especially in Indigenous and rural communities where monitoring access can vary.

Clinical Effectiveness In Canada

Can clonidine control blood pressure and help in ADHD in routine Canadian practice?

Canadian formulary reviews and Health Canada monographs confirm clonidine's role for essential hypertension as a centrally acting agent.

Extended‑release forms are used internationally and are commonly applied for paediatric ADHD, though product monographs and Health Canada listings should be checked for each marketed product.

In routine practice, clonidine lowers blood pressure effectively when used as add‑on therapy to other agents.

Extended‑release formulations reported in trials improve adherence for paediatric ADHD when given at bedtime.

DIN

Drug Identification Number assigned by Health Canada to each marketed product.

Formulary Coverage

Whether a provincial drug plan lists a product and what restrictions apply.

Special Authorization

A provincial approval process required when a product is not routinely listed.

Clinicians must consult Health Canada’s Drug Product Database and provincial formularies (Ontario Drug Benefit, BC PharmaCare, RAMQ) for exact DINs and coverage rules.

Indications And Expanded Uses

What is clonidine officially for, and when is it used off‑label?

Regulators such as the US FDA list clonidine for hypertension and certain ER products for ADHD, and EMA/national bodies maintain similar registrations.

In Canada the primary approved indication is antihypertensive use, with extended‑release clonidine widely used for paediatric ADHD in practice based on international RCT evidence.

• Approved:
  • Essential hypertension (typical start 0.1 mg twice daily, titrate up; typical maximum ~2.4 mg/day).
  • ADHD for specific ER products (typical paediatric start 0.1 mg at bedtime, titrate weekly to ~0.4 mg/day in trials).
• Off‑Label (Specialist Use):
  • Epidural infusion for severe cancer pain (Duraclon injection — specialist setting).
  • Treatment of withdrawal syndromes under supervision.
  • Migraine prevention or vasomotor symptom management in selected cases.

When clonidine is used off‑label, document consent and monitoring plans, especially where follow‑up is spaced out, as in some First Nations communities.

Composition And Brand Landscape

Which brands and manufacturers supply clonidine and what should Canadian patients expect?

Clonidine hydrochloride is the active moiety in most marketed products worldwide.

Brand names in global dossiers include Catapres (tablets), Catapres‑TTS (patches), Duraclon (injection), Kapvay and Nexiclon XR (ER tablets), and generics labelled Clonidina or Clonidin in some regions.

• Pros And Cons Of Brand Vs Generic:
  • Brands may offer consistent blister packaging and manufacturer support.
  • Generics often reduce cost but packaging and tablet scoring may vary.
  • Blister counts commonly 30 or 60 tablets; check pharmacy labelling for bilingual (EN/FR) instructions.

Major international manufacturers include Boehringer Ingelheim, Mylan, Teva, and Sandoz, with regional generics from other suppliers.

Contraindications And Special Precautions

Who should avoid clonidine and what monitoring is required?

Absolute contraindications include known hypersensitivity to clonidine and severe bradyarrhythmias or second‑ or third‑degree AV block without a pacemaker.

Relative precautions include recent myocardial infarction, severe coronary insufficiency, marked bradycardia, significant renal impairment, and a history of depression.

• Monitoring Parameters:
  • Blood pressure (sit and standing) at baseline and during titration.
  • Heart rate monitoring for bradycardia.
  • Orthostatic vitals when starting or increasing dose.
  • Mental health screening for depressive symptoms.
  • Renal function assessment when impairment is suspected.

Rebound Hypertension

Severe rise in blood pressure that can occur after abrupt discontinuation of clonidine.

Orthostatic Hypotension

Drop in blood pressure on standing that may cause dizziness or fainting.

Elderly patients and patients living in remote Indigenous or northern communities often start at lower doses and require clear follow‑up plans that community pharmacists can help coordinate.

Dosage Guidelines

How should clonidine be dosed safely for different patients?

Start low and titrate slowly according to product monographs and clinical guidelines.

• Practical Tips:
  • Take immediate‑release tablets at regular times each day.
  • Give ER formulations at bedtime for ADHD to reduce daytime drowsiness.
  • If a dose is missed, take as soon as remembered unless the next dose is near; do not double up.

Document the DIN and pharmacy brand on the medication record to help with continuity, as provincial formularies may restrict forms on coverage lists.

Interactions Overview

Worried about what mixes badly with clonidine?

Key interacting drug classes include central nervous system depressants, other antihypertensives, beta‑blockers, and tricyclic antidepressants.

Clinically important effects include additive hypotension or bradycardia when combined with other BP‑lowering drugs, and the potential for reduced antihypertensive response with some antidepressants.

• Common Interacting Classes:
  • CNS depressants and sedatives (enhanced sedation).
  • Beta‑blockers (risk of bradycardia).
  • Tricyclic antidepressants (can antagonize clonidine effect).
  • MAO inhibitors (careful monitoring required).
  • Local anaesthetics in epidural use — specialist consideration.

Advise Canadian patients to avoid excess alcohol and to check over‑the‑counter cold remedies that contain decongestants before combining with clonidine.

Cultural Perceptions And Patient Habits

What do Canadian patients say about taking catapres or clonidine?

Patient forums and community feedback show mixed views: many value clonidine’s efficacy and lower cost as generic clonidine, while others report drowsiness and adherence challenges.

Rural patients often report delays in pharmacy access and limited home blood‑pressure monitoring devices.

Indigenous communities commonly raise concerns about culturally safe counselling and continuity of care.

• Common Patient Concerns:
  • Drowsiness and fatigue, especially on initiation.
  • Dry mouth and constipation.
  • Need to taper to avoid rebound hypertension.
  • Skin reactions with patches.

Community pharmacists at major chains such as Shoppers Drug Mart, Jean Coutu, and London Drugs often provide medication reviews and arrange follow‑up phone checks to support adherence.

Availability And Pricing Patterns

How easy and expensive is it to get catapres in Canada?

Catapres and generic clonidine are widely distributed, with pricing that varies by province and between brand and generic versions.

Packaging commonly includes blister strips of 30 or 60 tablets and sealed foil pouches for patches.

Provincial drug plans (Ontario Drug Benefit, BC PharmaCare, RAMQ) include coverage criteria that affect out‑of‑pocket cost, and extended‑release products may require special authorizations.

In our online pharmacy, catapres is available without a prescription, with discreet delivery to Canada in 5–14 days.

For remote communities, provincial programs and mail‑order pharmacies often help maintain continuity of supply.

Comparable Medicines And Preferences

What are reasonable alternatives to clonidine and when might they be chosen?

Alternatives include methyldopa and guanfacine for centrally acting effects, while ACE inhibitors, ARBs, and calcium‑channel blockers remain first‑line for many patients with hypertension.

• Pros / Cons Checklist:
  • Clonidine: effective as add‑on; higher sedation risk; renal dosing required.
  • Guanfacine: often preferred for ADHD due to a different side‑effect profile and selectivity for alpha‑2A receptors.
  • Methyldopa: used in pregnancy where appropriate; central side effects possible.
  • ACEi/ARB/CCB: first‑line for hypertension with strong guideline support and fewer central sedative effects.

Prescribers consider formulary coverage, pill burden, and patient preference when selecting alternatives, and provincial formularies may favour certain options.

FAQ

Q: Is clonidine approved in Canada?

A: Clonidine products are regulated internationally and are prescription‑only in most jurisdictions.

Q: What if I miss a dose?

A: Take as soon as you remember unless the next dose is near; do not double up. Consult a pharmacist for ER products.

Q: Can I stop clonidine suddenly?

A: No. Abrupt discontinuation risks rebound hypertension and requires clinician‑led tapering.

Q: Will it make me sleepy at work or school?

A: Sedation is common, especially when starting. Bedtime ER dosing for ADHD and slow titration reduce daytime drowsiness.

Q: How do I get it covered?

A: Check provincial plans like ODB, PharmaCare, or RAMQ and ask your pharmacist to assist with special authorization if needed.

Data Highlight: Tapering requirement — clonidine must be tapered to avoid rebound hypertensive crisis.

Rural patients should arrange monitoring through a local nurse practitioner or pharmacy where primary care access is limited.

Guidelines For Proper Use

How should pharmacists and patients use catapres safely and effectively?

Best practice is start‑low, titrate‑slow, monitor blood pressure and heart rate, avoid abrupt cessation, and counsel on interactions and side effects.

Store tablets at room temperature (20–25°C) and keep patches in their original pouch.

• Stepwise Checklist:
  • Confirm DIN and brand when dispensing.
  • Review comorbidities such as renal, cardiac disease, and depression.
  • Set a monitoring schedule for BP/HR and renal function.
  • Document bilingual counselling and establish a taper plan.
  • Use telehealth and culturally safe resources for remote or Indigenous communities.

ER vs Immediate‑Release

ER formulations release drug over time and are used for ADHD bedtime dosing; immediate‑release tablets require timed dosing.

Community pharmacy services such as medication reviews at Shoppers Drug Mart or Rexall can support adherence and monitoring for patients on clonidine.

Delivery Across Canada (English)